Sivro Mirza, Omerović Đemil, Lazović Faruk, Papović Adnan
Department of Orthopaedics and Traumatology, Cantonal Hospital Zenica, Zenica, Bosnia and Herzegovina.
Clinic of Orthopaedics and Traumatology, Clinical Centre, University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
Med Glas (Zenica). 2025 Jan 1;22(1):121-126. doi: 10.17392/1887-22-01.
To determine the effects of high peri- and postoperative doses of vitamin C administration on severity of pain in postoperative period and functional outcome of the patients with trochanteric fracture treated with intramedullary nailing during a three-month follow-up.
A prospective, randomized, pilot study included 56 patients who were randomly divided into vitamin C (intervention) and control groups. In the intervention group, patients received vitamin C perioperatively by an intravenous route for 2 days, and oral vitamin C for 38 days postoperatively. Baseline characteristics, postoperative metamizole consumption, Visual Analogue Scale (VAS) score, Harris Hip Score (HHS) value, and the prevalence of complications were evaluated in both groups.
No significant differences were noted between the groups regarding age, gender, length of hospitalization, and distribution in fracture type. Postoperative metamizole consumption was notably higher in the control group compared to the vitamin C group (p=0.006). Postoperative VAS score was higher in the control group (p< 0.05). No significant differences in HHS values were detected between the groups at 6 and 12 weeks postoperatively (p=0.655 and p=0.755, respectively). The group variable significantly contributed to VAS score, and age and gender variables significantly contributed to HHS value.
A significant reduction of subjective pain levels and lower analgesic consumption was found in patients who received vitamin C, suggesting that it should be considered as an adjuvant agent for analgesia in patients with hip fracture.
确定围手术期和术后高剂量维生素C给药对术后疼痛严重程度以及采用髓内钉固定治疗的转子间骨折患者在三个月随访期间功能结局的影响。
一项前瞻性、随机、试点研究纳入了56例患者,这些患者被随机分为维生素C组(干预组)和对照组。干预组患者围手术期通过静脉途径接受2天的维生素C治疗,术后口服维生素C 38天。评估两组的基线特征、术后安乃近消耗量、视觉模拟评分(VAS)、Harris髋关节评分(HHS)值以及并发症发生率。
两组在年龄、性别、住院时间和骨折类型分布方面无显著差异。与维生素C组相比,对照组术后安乃近消耗量显著更高(p = 0.006)。对照组术后VAS评分更高(p < 0.05)。术后6周和12周时,两组HHS值无显著差异(分别为p = 0.655和p = 0.755)。组变量对VAS评分有显著影响,年龄和性别变量对HHS值有显著影响。
接受维生素C治疗的患者主观疼痛水平显著降低且镇痛药物消耗量减少,表明维生素C应被视为髋部骨折患者镇痛的辅助药物。